BOCA RATON, Fla.—Jan. 15, 2010 -- Greyson International, Inc. (GYSN.PK), a publicly traded entity that has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application, announced today that CEO Harvey Tauman will be interviewed by Stockgoodies.com, a G6 Stocks community at 8:30 a.m. ET on January 19, 2010.

The interview can be heard on the Stock Goodies homepage, www.stockgoodies.com.

Tauman will introduce Greyson International and provide listeners with management’s vision for the Company in 2010 and beyond:  The Company also recently announced it’s plans to appear on ShopNBC (ValueVision TV, NASDAQ: VVTV), a national television shopping network, to introduce for the first time its series of Trilexon® products.

About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonproducts.com, join the Greyson Facebook group page by visiting www.facebook.com and searching “Greyson Products” or follow Greyson on Twitter at www.twitter.com/greysonproducts.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.